Remus Pharmaceuticals Ltd
REMUS
Company Profile
Business description
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.
Contact
Ambli bopal Road
1101 to 1103, South Tower, One 42
Behind Ashok Vatika
Near Jayantilal Park BRTS
AhmedabadGJ380054
INDT: +91 7929999857
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 March 2026
Employees
48
Stocks News & Analysis
stocks
ASX reporting season wrap: BHP, banks, CSL bloodbath and more
A round up of notable stories and reactions as ASX earnings season continues.
stocks
Stock showdown: How do ASX healthcare giants compare on key investing criteria?
Our healthcare analyst Shane Ponraj helps me compare the moatiness and growth prospects of two sector heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,284.20 | 51.60 | 0.56% |
| CAC 40 | 7,938.29 | 34.74 | -0.44% |
| DAX 40 | 24,293.34 | 16.37 | 0.07% |
| Dow JONES (US) | 44,785.50 | 152.81 | -0.34% |
| FTSE 100 | 9,309.20 | 21.06 | 0.23% |
| HKSE | 25,104.61 | 61.33 | -0.24% |
| NASDAQ | 21,100.31 | 72.54 | -0.34% |
| Nikkei 225 | 42,610.17 | 278.38 | -0.65% |
| NZX 50 Index | 13,194.07 | 122.77 | 0.94% |
| S&P 500 | 6,370.17 | 25.61 | -0.40% |
| S&P/ASX 200 | 9,019.10 | 45.40 | 0.51% |
| SSE Composite Index | 3,771.10 | 4.89 | 0.13% |